These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1136 related items for PubMed ID: 27102539

  • 1. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO, Kwak SY, An HJ, Bae IH, Park MJ, Han YH.
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [Abstract] [Full Text] [Related]

  • 2. miR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin.
    Kwak SY, Yoo JO, An HJ, Bae IH, Park MJ, Kim J, Han YH.
    J Mol Cell Biol; 2016 Oct 01; 8(5):372-383. PubMed ID: 27282406
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z.
    Carcinogenesis; 2013 Mar 01; 34(3):539-49. PubMed ID: 23188671
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP, Zhou HJ, Qin J, Luo Y, Zhang T.
    Oncol Rep; 2017 Nov 01; 38(5):3144-3152. PubMed ID: 29048659
    [Abstract] [Full Text] [Related]

  • 5. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J, Xie F, Bao X, Chen W, Xu Q.
    Mol Cancer; 2014 May 24; 13():121. PubMed ID: 24885626
    [Abstract] [Full Text] [Related]

  • 6. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW, Chen PM, Hsieh YH, Weng CC, Chang CW, Yao CC, Hu LY, Wu PE, Shen CY.
    Oncotarget; 2015 Dec 29; 6(42):44222-38. PubMed ID: 26528854
    [Abstract] [Full Text] [Related]

  • 7. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM, Akcakanat A, Adkins F, Evans K, Chen H, Wei C, Milton DR, Li Y, Do KA, Janku F, Meric-Bernstam F.
    Oncotarget; 2015 Aug 14; 6(23):19500-13. PubMed ID: 25944619
    [Abstract] [Full Text] [Related]

  • 8. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.
    Zhao Z, Fan X, Jiang L, Xu Z, Xue L, Zhan Q, Song Y.
    J Genet Genomics; 2017 Feb 20; 44(2):75-84. PubMed ID: 28161325
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM.
    Oncogene; 2014 Jul 31; 33(31):4069-76. PubMed ID: 24013226
    [Abstract] [Full Text] [Related]

  • 10. miR-410-3p suppresses breast cancer progression by targeting Snail.
    Zhang YF, Yu Y, Song WZ, Zhang RM, Jin S, Bai JW, Kang HB, Wang X, Cao XC.
    Oncol Rep; 2016 Jul 31; 36(1):480-6. PubMed ID: 27221455
    [Abstract] [Full Text] [Related]

  • 11. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY, Teng SC, Cheng TH, Wu KJ.
    Cancer Lett; 2016 Aug 01; 378(1):59-67. PubMed ID: 27177472
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT.
    J Nutr Biochem; 2015 Jun 01; 26(6):675-85. PubMed ID: 25792283
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma.
    Zhang Z, Zhang M, Chen Q, Zhang Q.
    Cancer Gene Ther; 2017 Feb 01; 24(2):83-88. PubMed ID: 28186090
    [Abstract] [Full Text] [Related]

  • 15. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY, Park MK, Park JH, Lee HJ, Shin DH, Kang Y, Lee CH, Kong G.
    Oncogene; 2014 Mar 06; 33(10):1325-35. PubMed ID: 23474752
    [Abstract] [Full Text] [Related]

  • 16. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.
    Xia W, Ma X, Li X, Dong H, Yi J, Zeng W, Yang Z.
    Oncol Rep; 2015 Aug 06; 34(2):655-62. PubMed ID: 26035427
    [Abstract] [Full Text] [Related]

  • 17. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Dong P, Xiong Y, Watari H, Hanley SJ, Konno Y, Ihira K, Yamada T, Kudo M, Yue J, Sakuragi N.
    J Exp Clin Cancer Res; 2016 Sep 05; 35(1):132. PubMed ID: 27596137
    [Abstract] [Full Text] [Related]

  • 18. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H, Bai Y, Qiu S, Zheng L, Huang L, Liu T, Wang X, Liu Y, Xu N, Yan X, Guo H.
    Oncotarget; 2015 Apr 20; 6(11):8914-28. PubMed ID: 25871397
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV, Martin EC, Segar HC, Miller DF, Buechlein A, Rusch DB, Nephew KP, Burow ME, Collins-Burow BM.
    Oncotarget; 2015 Jun 30; 6(18):16638-52. PubMed ID: 26062653
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 57.